(4S,5S)-5-(tert-Butyldimethylsilanyloxymethyl)-4-[1,3]dioxolan-2-yldihydrofuran-2-one → (3S,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-ol

According to the above general procedure, a solution containing 216 mg (0.714 mmol) (4S,5S)-5-(tert-butyldimethylsilanyloxymethyl)-4-[1,3]-dioxolan-2-yldihydrofuran-2-one (3a) in THF (25 mL) was reduced with 98 mg (2.58 mmol) LiAlH4 in THF (7 mL) to give the crude protected triol (4) (132 mg, 96%). The crude triol (4) (76 mg (0.40 mmol)) was cyclized in 6 mL acidified THF:water (5:1). Column chromatography (silica gel 20 g, ethyl methanol in CH2Cl2 10%) gave compound (5) (37.6 mg, 84%) as a colorless solid, Rf=0.35, [α]25D −25°, c 1.0, MeOH. 1H-NMR (400 MHz, CDCl3) δ: 1.67 (mc, 1H), 2.14 (mc, 1H), 2.63 (bs, 1H), 2.79 (mc, 1H), 3.75-3.88 (m, 3H), 3.94 (dd, 1H, J=3.0 Hz, J=10.2 Hz), 4.20 (d, 1H, J=2.7 Hz), 5.86 (d, 1H, J=4.9 Hz). 13C-NMR (125.8 MHz, CDCl3, Dept) δ: 29.19 (−), 52.38 (+), 69.52 (−), 75.60 (−), 78.14 (=), 109.23 (+). C6H10O3; Exact Mass: 130.06; Mol. Wt.: 130.14; C, 55.37; H, 7.74; O, 36.88.

1. customto give the crude

ORD record

ord-98973d9f30084cbfac76e0fc1df9a574

Source dataset

uspto-grants-2005_07

DOI

10.6084/m9.figshare.5104873.v1

Patent number

US06919465B2